The Challenge GLP-1s are an important new tool for weight loss but as with any tool, they have their limitations
The Protein & Calcium Combo Protein is the king of satiety
Figure 1 Discussion In the presented case of a newly diagnosed patient with type 2 diabetes, euDKA occurred at the very early onset after initiation of combined therapy with GLP-1RA and SGLT2i, in the absence of infection or other precipitating factors (such as alcohol overdose, pancreatitis, pregnancy), and proved refractory to standard therapy with insulin, glucose, and fluid resuscitation
Always consult with your healthcare provider before making changes to your medication.
We must inform people about how their daily decisions impact therapeutic effectiveness
We are here to listen and provide the support you need